Table 3. Predictors of GVL at baseline and at month 12 among participants receiving ART.

	Variables	adj. OR	95% CI	P-value
Baseline model	Plasma viral load	2.47	1.66, 3.67	< 0.0001
AIC = 183.62 (N = 96)	Detectable IL-1β	1.68	1.32, 2.15	<0.0001
	Age	1.04	0.99, 1.09	0.11
	N. gonorrhoea at baseline.	4.6	1.26, 16.82	0.021
Month 12 model	Genital viral load at baseline	0.62	(0.12, 3.27)	0.57
AIC 24.6 (N = 49)	(Log10 RNA copies/mL)
	IL-8 at baseline (Log10 pg/mL)	5.47	(0.61, 49.52)	0.13
	Plasma Viral load at 12 month	2.3	(0.84, 6.3)	0.1
	(Log10 RNA copies/mL)
	MIP-1β at month 12	4.53	(0.96, 21.32)	0.06
	(Log10 pg/mL)

Predictors of genital viral load ≥40 copies/mL at baseline and at month 12 were determined. Ninety six women initiating ART were included in the analysis at baseline. Forty-nine women receiving ART had viral load data available at month 12 and were included in the analysis at month 12. The variables included were:

At baseline: Plasma viral load, CD4, age, IL-8, IP-10, MIP-1b, VEGF, IL-6, GCSF, IL-1β, N. gonorrhoea, Chlamydia trachomatis, Trichomonas vaginalis, HSV2

At month 12: Use of family planning method, marital status, Trichomonas vaginalis at baseline & month 12, IL-8 at baseline & month 12, IP-10 at baseline & month 12, MIP-1b at month 12, IL-1β at month 12, IL-1RA at month 12, IL-6 at month 12, Genital VL at baseline, plasma VL at month 12.

AIC: Aikaike Information criteria.